Mary G. Amato

3.3k total citations
57 papers, 2.0k citations indexed

About

Mary G. Amato is a scholar working on Geriatrics and Gerontology, Health Information Management and Emergency Medical Services. According to data from OpenAlex, Mary G. Amato has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Geriatrics and Gerontology, 22 papers in Health Information Management and 20 papers in Emergency Medical Services. Recurrent topics in Mary G. Amato's work include Pharmaceutical Practices and Patient Outcomes (31 papers), Electronic Health Records Systems (22 papers) and Patient Safety and Medication Errors (20 papers). Mary G. Amato is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (31 papers), Electronic Health Records Systems (22 papers) and Patient Safety and Medication Errors (20 papers). Mary G. Amato collaborates with scholars based in United States, United Kingdom and Switzerland. Mary G. Amato's co-authors include Henry I. Bussey, Elaine Chiquette, David W. Bates, Diane L. Seger, Mary O’Keefe, Gilbert Ramı́rez, Cynthia D. Mulrow, Adam Wright, Adrian Wong and Gordon D. Schiff and has published in prestigious journals such as Critical Care Medicine, Medical Care and Journal of General Internal Medicine.

In The Last Decade

Mary G. Amato

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary G. Amato United States	23	797	501	459	424	349	57	2.0k
Patricia M. L. A. van den Bemt Netherlands	40	2.6k 3.2×	569 1.1×	411 0.9×	819 1.9×	1.6k 4.5×	187	4.9k
Maarten J. ten Berg Netherlands	18	532 0.7×	826 1.6×	458 1.0×	183 0.4×	311 0.9×	38	1.9k
Charles E. Leonard United States	26	268 0.3×	196 0.4×	320 0.7×	516 1.2×	96 0.3×	127	2.3k
Christianne L. Roumie United States	37	499 0.6×	136 0.3×	463 1.0×	949 2.2×	129 0.4×	161	4.0k
Jacob Abarca United States	15	682 0.9×	249 0.5×	105 0.2×	196 0.5×	287 0.8×	31	1.2k
William Galanter United States	24	368 0.5×	604 1.2×	197 0.4×	237 0.6×	307 0.9×	86	1.7k
Andrew C. Seger United States	24	2.6k 3.3×	1.2k 2.3×	452 1.0×	561 1.3×	1.8k 5.1×	42	5.2k
Peter J. Zed Canada	29	733 0.9×	38 0.1×	368 0.8×	366 0.9×	313 0.9×	108	2.5k
Ingrid Sketris Canada	29	1.1k 1.4×	112 0.2×	377 0.8×	313 0.7×	275 0.8×	158	3.6k
Marc Afilalo Canada	25	383 0.5×	63 0.1×	291 0.6×	282 0.7×	177 0.5×	80	2.6k

Countries citing papers authored by Mary G. Amato

Since Specialization

Citations

This map shows the geographic impact of Mary G. Amato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary G. Amato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary G. Amato more than expected).

Fields of papers citing papers by Mary G. Amato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary G. Amato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary G. Amato. The network helps show where Mary G. Amato may publish in the future.

Co-authorship network of co-authors of Mary G. Amato

This figure shows the co-authorship network connecting the top 25 collaborators of Mary G. Amato. A scholar is included among the top collaborators of Mary G. Amato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary G. Amato. Mary G. Amato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amato, Mary G., Diane L. Seger, Lynn A. Volk, et al.. (2025). Clinician Attitudes and Perceptions of Point-of-Care Information Resources and Their Integration Into Electronic Health Records: Qualitative Interview Study. JMIR Medical Informatics. 13. e60191–e60191.

Seger, Diane L., et al.. (2024). Straight to the point: evaluation of a Point of Care Information (POCI) resource in answering disease-related questions. Journal of the Medical Library Association JMLA. 112(1). 13–21. 1 indexed citations

Seger, Diane L., et al.. (2024). A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator. Drug Safety. 47(12). 1235–1243. 2 indexed citations

Syrowatka, Ania, Lynn A. Volk, Heba H Edrees, et al.. (2023). Performance of a Web-Based Reference Database With Natural Language Searching Capabilities: Usability Evaluation of DynaMed and Micromedex With Watson. JMIR Human Factors. 10. e43960–e43960. 6 indexed citations

Edrees, Heba H, et al.. (2022). Intelligent Telehealth in Pharmacovigilance: A Future Perspective. Drug Safety. 45(5). 449–458. 16 indexed citations

Gammal, Roseann S., et al.. (2021). Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events. Drug Safety. 44(5). 601–607. 4 indexed citations

Syrowatka, Ania, Wenyu Song, Mary G. Amato, et al.. (2021). Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. The Lancet Digital Health. 4(2). e137–e148. 42 indexed citations

Amato, Mary G., et al.. (2020). Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts. Journal of the American Medical Informatics Association. 28(6). 1081–1087. 21 indexed citations

Wright, Adam, Dustin McEvoy, Skye Aaron, et al.. (2019). Structured override reasons for drug-drug interaction alerts in electronic health records. Journal of the American Medical Informatics Association. 26(10). 934–942. 34 indexed citations

10.

Wong, Adrian, Diane L. Seger, Mary G. Amato, et al.. (2018). Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit. Drug Safety. 42(4). 573–579. 13 indexed citations

11.

Wong, Adrian, Mary G. Amato, Diane L. Seger, et al.. (2017). Evaluation of medication-related clinical decision support alert overrides in the intensive care unit. Journal of Critical Care. 39. 156–161. 26 indexed citations

12.

Amato, Mary G., Lynn A. Volk, Alejandra Salazar, et al.. (2017). Analysis of variations in the display of drug names in computerized prescriber-order-entry systems. American Journal of Health-System Pharmacy. 74(7). 499–509. 7 indexed citations

13.

Her, Qoua L., Mary G. Amato, Diane L. Seger, et al.. (2016). The frequency of inappropriate nonformulary medication alert overrides in the inpatient setting. Journal of the American Medical Informatics Association. 23(5). 924–933. 13 indexed citations

14.

Maniam, Nivethietha, Sarah P. Slight, Diane L. Seger, et al.. (2014). An Evaluation of Computerized Medication Alert Override Behavior in Ambulatory Care.. AMIA. 1 indexed citations

15.

Leung, Alexander A. C., Carol Keohane, Stuart R. Lipsitz, et al.. (2013). Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool. Journal of the American Medical Informatics Association. 20(e1). e85–e90. 22 indexed citations

16.

Carter, Barry L., Daniel C. Malone, Sarah J. Billups, et al.. (2001). Interpreting the findings of the IMPROVE study. American Journal of Health-System Pharmacy. 58(14). 1330–1337. 42 indexed citations

17.

Ellis, Samuel L., Barry L. Carter, Daniel C. Malone, et al.. (2000). Clinical and Economic Impact of Ambulatory Care Clinical Pharmacists in Management of Dyslipidemia in Older Adults: The IMPROVE Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(12). 1508–1516. 126 indexed citations

18.

Malone, Daniel C., Barry L. Carter, Sarah J. Billups, et al.. (2000). An Economic Analysis of a Randomized, Controlled, Multicenter Study of Clinical Pharmacist Interventions for High‐Risk Veterans: The IMPROVE Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(10). 1149–1158. 75 indexed citations

19.

Brand, Michael, et al.. (1997). The Treatment of Chronic Constipation in Adults. Journal of General Internal Medicine. 12(1). 15–24. 113 indexed citations

20.

Hart, Robert G., et al.. (1996). Warfarin for prevention of stroke: A practical, clinical review. The Neurologist. 2(6). 319–341. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact